* Report says Biglaw firms are more enthusiastic about merging this year. Shearman's wondering why y'all got to go rubbing salt on it. [Reuters] * Goldman Sachs estimates that AI will replace 44 percent of legal tasks. Nice try, Goldman. You're not gettin
Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech. The post Regulatory Roundup:
Bye-bye Biglaw, hello Trumpland. The post Biglaw Partner Leaves Firm To Represent Donald Trump In Criminal Case appeared first on Above the Law.
If your company is large enough to have a general counsel, more factors at play will drive the need to measure and reduce your carbon footprint. The post What GCs Need To Know About Carbon Right Now appeared first on Above the Law.